Sports Supplement Acquisition Group Announces Closing of Acquisition

2009-01-14 22:32:02 -

Sports Supplement Acquisition Group, Inc. (formerly Cynergi Holdings, Inc.) (OTC BB: CYGH), announces the closing of the acquisition of Sports Supplement Acquisition Group, Inc. (SSAG), a previously unrelated Delaware Corporation, a company focused on the acquisition of companies engaged in the production and distribution of innovative sports supplements.


SSAG is a sales and marketing company formed to acquire brands and companies currently operating in the sports performance and weight management markets. Since our formation, we have been actively engaged in seeking out companies that management believes would integrate efficiently into our portfolio. SSAG closed its platform acquisition of the ErgoPharm brand from Proviant Technologies on December 10, 2008. Revenues for SSAG consist of sales of nutritional supplements. Revenues for the ErgoPharm brand during the nine-month period ending September 30, 2008 were $3,151,739 and the net profit for the ErgoPharm brand during the same period was $ 645,281.


SSAG has filed a Form 8-K Current Report with the SEC which provides a detailed description of its business and the terms of the transaction. This report is available on the SEC website, www.sec.gov.


Information regarding the business of SSAG can be found at www.ergopharm.net





This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and the company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our recent current reports on Form 8-K, our annual report on Form 10-KSB, our quarterly reports on Form 10-QSB and other periodic and current reports filed from time-to-time with the Securities and Exchange Commission.








Sports Supplement Acquisition Group, Inc.

James Klein, 888-501-3746